Terms: = Adult Hodgkin lymphoma AND BCR, FLJ16453, 613, ENSG00000186716, BCR1, D22S662, D22S11, CML, P11274, PHL, ALL AND Diagnosis
286 results:
1. Comparing symptom clusters in cancer survivors by cancer diagnosis: A latent class profile analysis.
Lee LJ; Han CJ; Saligan L; Wallen GR
Support Care Cancer; 2024 Apr; 32(5):308. PubMed ID: 38662054
[TBL] [Abstract] [Full Text] [Related]
2. Pulmonary lesions in early response assessment in pediatric hodgkin lymphoma: prevalence and possible implications for initial staging.
Stoevesandt D; Ludwig C; Mauz-Körholz C; Körholz D; Hasenclever D; McCarten K; Flerlage JE; Kurch L; Wohlgemuth WA; Landman-Parker J; Wallace WH; Fosså A; Vordermark D; Karlén J; Cepelová M; Klekawka T; Attarbaschi A; Hraskova A; Uyttebroeck A; Beishuizen A; Dieckmann K; Leblanc T; Daw S; Steglich J
Pediatr Radiol; 2024 May; 54(5):725-736. PubMed ID: 38296856
[TBL] [Abstract] [Full Text] [Related]
3. Epidemiology of pediatric hematological malignancies in Kazakhstan: Data from Unified National Electronic Healthcare System 2014-2021.
Mussina K; Kuanova B; Syssoyev D; Gaipov A; Poddighe D; Shaikhyzada K; Aimyshev T; Galiyeva D
Eur J Pediatr; 2024 Apr; 183(4):1683-1691. PubMed ID: 38214809
[TBL] [Abstract] [Full Text] [Related]
4. Indolent T-lymphoblastic proliferation involving hepatocellular carcinoma-presentation in novel settings and comprehensive review of literature.
Ghezavati A; Liang CA; Mais D; Nazarullah A
J Hematop; 2023 Sep; 16(3):167-175. PubMed ID: 38175402
[TBL] [Abstract] [Full Text] [Related]
5. Optimal dosage of rituximab for children with Burkitt lymphoma.
Huang S; Jin L; Yang J; Zhang M; Zhang Y; Peng Y; Duan Y; Zheng H
Ann Hematol; 2024 Mar; 103(3):893-903. PubMed ID: 38091052
[TBL] [Abstract] [Full Text] [Related]
6. [Characteristics and impact factors of SARS-CoV-2 infection in adult patients with relapsed/refractory B-cell non-hodgkin lymphoma receiving chimeric antigen receptor T-cell therapy].
Ge T; Liu H; Wang ZH; Cao Y; Zhang YC; Huang L; Qian WB; Zhou XX
Zhonghua Xue Ye Xue Za Zhi; 2023 Oct; 44(10):825-831. PubMed ID: 38049334
[No Abstract] [Full Text] [Related]
7. Spontaneous tumor lysis syndrome in a patient with chronic myeloid leukemia treated successfully with allopurinol.
Gartenberg A; Winkel M; Leonard N
Am J Emerg Med; 2024 Apr; 78():242.e1-242.e3. PubMed ID: 38007380
[TBL] [Abstract] [Full Text] [Related]
8. Health Care Resource Utilization and Total Costs of Care for adult Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia in the United States: A Retrospective Claims Analysis.
Ito D; Feng C; Fu C; Kim C; Wu J; Dalton D; Epstein J; Snider JT; DuVall AS
Clin Ther; 2024 Jan; 46(1):3-11. PubMed ID: 37981560
[TBL] [Abstract] [Full Text] [Related]
9. Impact of Social Disparities on 5-Year Survival Rates in Pediatric Hematologic Malignancies.
Chalfant V; Riveros C; Bechtel A; Bradfield SM; Stec AA
J Pediatr Hematol Oncol; 2024 Jan; 46(1):33-38. PubMed ID: 37910818
[TBL] [Abstract] [Full Text] [Related]
10. Testicular dysfunction at diagnosis in children and teenagers with haematopoietic malignancies improves after initial chemotherapy.
Lopez Dacal J; Prada S; Correa Brito L; Ropelato MG; Ballerini MG; Rodriguez ME; Gutiérrez ME; Soria M; Morán L; Ferraro C; Bedecarrás P; Drelichman G; Aversa L; Bergadá I; Rey RA; Grinspon RP
Front Endocrinol (Lausanne); 2023; 14():1135467. PubMed ID: 37260445
[TBL] [Abstract] [Full Text] [Related]
11. Late-onset Cognitive Impairment and Modifiable Risk Factors in adult Childhood Cancer Survivors.
Phillips NS; Stratton KL; Williams AM; Ahles T; Ness KK; Cohen HJ; Edelstein K; Yasui Y; Oeffinger K; Chow EJ; Howell RM; Robison LL; Armstrong GT; Leisenring WM; Krull KR
JAMA Netw Open; 2023 May; 6(5):e2316077. PubMed ID: 37256617
[TBL] [Abstract] [Full Text] [Related]
12. [Strategy of the French Society of Childhood Cancer (SFCE) for pediatric nodular lymphocyte predominant lymphoma].
Dourthe ME; Simonin M; Rigaud C; Haouy S; Montravers F; Ducou Le Pointe H; Garnier N; Minard-Colin V; Jo Molina T; Boudjemaa S; Leblanc T; Landman-Parker J
Bull Cancer; 2023 Sep; 110(9):968-977. PubMed ID: 37062647
[TBL] [Abstract] [Full Text] [Related]
13. Prognostic value of cross-lineage expression of the myeloid-associated antigens CD13 and CD33 in adult B-lymphoblastic leukemia: A large real-world study of 1005 patients.
Liao H; Lai H; Chen J; Shuai X; Zhang X; Yang Y; Lyu M; Zheng Q
Cancer Med; 2023 Apr; 12(8):9615-9626. PubMed ID: 36951610
[TBL] [Abstract] [Full Text] [Related]
14. Spectrum of second primary malignancies and cause-specific mortality in pediatric and adult langerhans cell histiocytosis.
Goyal G; Parikh R; Richman J; Abeykoon JP; Morlote D; Go RS; Bhatia S
Leuk Res; 2023 Mar; 126():107032. PubMed ID: 36758375
[TBL] [Abstract] [Full Text] [Related]
15. [Analysis of 42 cases of childhood superior vena cava syndrome associated with mediastinal malignancy].
Yang QS; Han YL; Cai JY; Gu S; Bai J; Ren H; Xu M; Zhang J; Zhang AA; Su M; Pan C; Wang Y; Tang JY; Gao YJ
Zhonghua Er Ke Za Zhi; 2022 Oct; 60(10):1026-1030. PubMed ID: 36207849
[No Abstract] [Full Text] [Related]
16. Longitudinal use of patient reported outcomes in pediatric leukemia and lymphoma reveals clinically relevant symptomatic adverse events.
Jacobs SS; Withycombe JS; Castellino SM; Lin L; Mack JW; McFatrich M; Baker JN; Freyer DR; Maurer SH; Mowbray C; Hinds PS; Reeve BB
Pediatr Blood Cancer; 2022 Dec; 69(12):e29986. PubMed ID: 36151978
[TBL] [Abstract] [Full Text] [Related]
17. Quantitative Plasma Proteomics to Identify Candidate Biomarkers of Relapse in Pediatric/Adolescent hodgkin lymphoma.
Repetto O; Caggiari L; De Zorzi M; Elia C; Mussolin L; Buffardi S; Pillon M; Muggeo P; Casini T; Steffan A; Mauz-Körholz C; Mascarin M; De Re V
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077307
[TBL] [Abstract] [Full Text] [Related]
18. [Analysis of Agranulocytosis Time and Its Influencing Factors in Patients with Hematological Malignancies Treated with rhIL-11 combined rhG-CSF].
Wei HM; Li ZJ; Wang LN
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Jun; 30(3):930-936. PubMed ID: 35680829
[TBL] [Abstract] [Full Text] [Related]
19. Hematopoietic Stem-Cell Transplant Utilization in Relapsed/Refractory hodgkin lymphoma: A Population-Level Analysis of Statewide Claims Data.
Waheed A; Rodday AM; Kumar AJ; Miller KB; Parsons SK
JCO Clin Cancer Inform; 2022 May; 6():e2100135. PubMed ID: 35584337
[TBL] [Abstract] [Full Text] [Related]
20. Retrospective single-center experience with OEPA/COPDAC and PET-CT based strategy for pediatric hodgkin lymphoma in a LMIC setting.
Palayullakandi A; Trehan A; Jain R; Kumar R; Mittal BR; Kapoor R; Srinivasan R; Kakkar N; Bansal D
Pediatr Hematol Oncol; 2022 Oct; 39(7):587-599. PubMed ID: 35271413
[TBL] [Abstract] [Full Text] [Related]
[Next]
